Zobrazeno 1 - 10
of 136
pro vyhledávání: '"K. Kolaric"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
mamm. 64:361-370
Chez le campagnol de Martino la croissance des racines des molaires apres la naissance permet d'utiliser leur longueur (R) comme un indicateur de l'âge absolu des individus. La longueur de la racine anterieure de la premiere molaire inferieure a ete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b548de9d606a0ca03eb043e311ad38d
https://doi.org/10.1515/mamm.2000.64.3.361
https://doi.org/10.1515/mamm.2000.64.3.361
Autor:
S. Eckhardt, M. Nekulova, Z. Mechl, I. Hindy, R. Tomek, J. Röthig, F. Gyergyay, K. Kolaric, Decker A, I. Sawinsky, S. Kerpel-Fronius
Publikováno v:
European Journal of Haematology. 38:67-69
SUMMARY Twenty-five breast cancer patients previously not exposed to adriamycin, were treated with 30 mg/m2/day aclarubicin for four consecutive days. Out of the 19 evaluable cases 1 CR and 2 PR were observed giving an overall remission rate of 16%.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c12967da8e618fddb05334f6f01eca73
https://doi.org/10.1111/j.1600-0609.1987.tb00026.x
https://doi.org/10.1111/j.1600-0609.1987.tb00026.x
Publikováno v:
Tumori Journal. 85:234-238
Background A prospective randomized clinical study was performed in patients with locally advanced or metastatic gastric cancer. The purpose of the study was to determine the activity of high doses of 5-fluorouracil and epirubicin (FE) vs the same co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b170d344f8fd1780047967d72fb90bf1
https://doi.org/10.1177/030089169908500404
https://doi.org/10.1177/030089169908500404
Autor:
S, Eckhardt, K, Kolaric, D, Vukas, E, Kánitz, Z, Schoket, J, Jassem, L, Vuletic, S, Jelic, Z, Mechl, I, Koza
Publikováno v:
Medical oncology and tumor pharmacotherapy. 7(1)
The purpose of the study was to investigate the antitumour activity and toxicity of high dose (120 mg m-2) single agent epirubicin therapy in untreated extensive small cell lung cancer patients. Out of 80 patients entered, 71 were evaluable for both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b1551290e6b577a9d10efc0ff877cc37
https://pubmed.ncbi.nlm.nih.gov/2160033
https://pubmed.ncbi.nlm.nih.gov/2160033
Autor:
S. Kerpel-Fronius, F. Gyergyay, I. Hindy, A. Decker, I. Sawinsky, K. Fäller, Z. Mechl, M. Nekulova, K. Kolaric, R. Tomek, J. Röthig, S. Eckhardt
Publikováno v:
Oncology. 44:159-163
Aclacinomycin A (ACM) in a daily dose of 30 mg/m2 was infused over 1 h on 4 consecutive days to 50 patients. Myelotoxicity was acceptable, nausea and vomiting was frequent, hair loss was mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::974a7b25b716c6e4706d0c0d115ccfb3
https://doi.org/10.1159/000226469
https://doi.org/10.1159/000226469
Autor:
Sándor Eckhardt, János Szántó, O. Cerar, V. Chylak, Z. Hernádi, I. Hindy, S. József, É. Juhos, K. Kolaric, J. Kopecny, I. Koza, Z. Mechl, K. Miksics, L. Németh, M. Pawlicki, S. Plesnicar, E. Ploch, Z. Schoket, Z. Stepanek, L. Svancarová, T. Vizhányó, B. Zuchovska
Publikováno v:
Oncology. 44:69-72
The therapeutic efficacy of the combination of cyclophosphamide + epirubicin + cisplatin was evaluated in 107 previously treated or untreated patients with advanced ovarian cancer. The overall response rate was 58.8%, complete remission 36.4% (mean d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51f1a4f30353af4888f8b712de78317a
https://doi.org/10.1159/000226447
https://doi.org/10.1159/000226447
Publikováno v:
Oncology Research and Treatment. 11:238-240
23 Patienten mit Extravasatkomplikationen nach intravenoser Zytostatikatherapie wurden in einer offenen Pilotstudie mit Tetrachlor-decaoxid (TCDO, Oxoferin®) als lokalem Wundfeucht-Therapeutikum behan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::741c9740b8d78f6574e5024c42217251
https://doi.org/10.1159/000216533
https://doi.org/10.1159/000216533
Publikováno v:
Cancer chemotherapy reports. 59(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24caf8d876b6e0dd6d1bbdd6bb580f61
https://pubmed.ncbi.nlm.nih.gov/1222391
https://pubmed.ncbi.nlm.nih.gov/1222391
Autor:
S, Eckhardt, J, Szántó, O, Cerar, V, Chylak, Z, Hernádi, I, Hindy, S, József, E, Juhos, K, Kolaric, J, Kopecny
Publikováno v:
Oncology. 44(2)
The therapeutic efficacy of the combination of cyclophosphamide + epirubicin + cisplatin was evaluated in 107 previously treated or untreated patients with advanced ovarian cancer. The overall response rate was 58.8%, complete remission 36.4% (mean d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7a6ebfb21cedb40aeafb4837a68ea016
https://pubmed.ncbi.nlm.nih.gov/3554083
https://pubmed.ncbi.nlm.nih.gov/3554083